3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Lung Neoplasms
2
Leukemia, Myeloid, Acute
2
Carcinoma, Renal Cell
2
Brain Neoplasms
2
Urinary Bladder Neoplasms
1
Ureteral Neoplasms
1
Triple Negative Breast Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Rectal Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pancreatic Neuroendocrine Tumors (pNET)
1
Oropharyngeal Neoplasms
1
Non-Muscle Invasive Bladder Neoplasms
1
Neoplasms
1
Melanoma
1
Lymphoma, Mantle-Cell
1
Head and Neck Neoplasms
1
Carcinoma, Squamous Cell
1
Breast Neoplasms
1
Breast Carcinoma In Situ
1
Anus Neoplasms
1
Anatomic Stage II Breast Cancer AJCC v8
1
Anal Canal Carcinoma
1
Interventions
Magnetic Resonance Spectroscopy
9
Specimen Handling
8
Cisplatin
5
Cetuximab
5
Platinum
4
1,2-diaminocyclohexaneplatinum II citrate
4
cemiplimab
3
Radiotherapy
3
Immunoglobulin G
3
Disulfides
3
Biopsy
3
(225)Ac-DOTA-c(RGDyK)
3
pembrolizumab
2
Radiotherapy, Intensity-Modulated
2
Radiation
2
Nivolumab
2
Carboplatin
2
Bevacizumab
2
trastuzumab deruxtecan
1
temsirolimus
1
niraparib
1
ipatasertib
1
durvalumab
1
dostarlimab
1
cabozantinib
1
atezolizumab
1
Valproic Acid
1
Ultrasonography
1
Transurethral Resection of Bladder
1
Tramadol
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Mouth Neoplasms
×
Watchful Waiting
×
30 days
×
Clear all
No trials found.